pharmaphorum10d
Drug-digital dual therapy for depression starts phase 2
Apimostinel has a similar mode of action to ketamine and derivatives like Johnson & Johnson's Spravato (esketamine) – ...
Asia One6d
'It sneaked in quietly, causing anxiety and confusion': Man shares struggles with autoimmune condition
Hazwady Nazran, now 38, was hospitalised with mysterious and terrifying symptoms such as violent episodes, paranoid delusions, confusion, memory loss and seizures. If his wife, Dr Miria Hastuti ...
His condition was almost misdiagnosed as madness
A rare autoimmune disorder was behind Mr Hazwady Nazran's paranoid delusions, memory loss and seizures. Read more at ...
GNT Pharma Reports Significant Improvements in Stroke Patients Treated with its pioneering Phase 3 Drug Nelonemdaz™
GNT Pharma Co. Ltd, a late-stage pharmaceutical company founded in 1998 with offices in Seoul Korea, Italy and USA, announced today the results of its latest Phase II ('SONIC') and Phase III ('Rodin') ...
Folkestone man, 29, who had vivid night terror now suffers seizures and violent outbursts after 'devastating' encephalitis diagnosis
A once fit and healthy young man has had his life turned upside down by a devastating rare condition after he suddenly ...
Man's terrifying nightmares were a sign of a deadly brain condition that's left him fighting for his life in intensive care
Ben Tarver, 29, from Folkestone, Kent, awoke in the middle of the night on September 11 and told his partner Liam Nougher, 26 ...
Fit and healthy man's life ruined after horrifying night terror caused by rare disease
Ben Tarver, 29, began suffering vivid night terrors, hallucinations and seizures after developing Anti-NMDA Receptor ...
Pharmaceutical Technology9d
Risk adjusted net present value: What is the current valuation of VistaGen Therapeutics’s AV-101?
AV-101 is a small molecule commercialized by VistaGen Therapeutics, with a leading Phase I program in Drug-Induced Dyskinesia.
Man, 29, battling ‘brain-swelling disease’ after night terror left him feeling like he was ‘inside his nightmare’
A ONCE fit and healthy man has had his life turned upside down after suffering a terrifying night terror. Ben Tarver, 29, ...
Pharmaceutical Technology6d
Risk adjusted net present value: What is the current valuation of Atai Life Sciences’s RL-007?
RL-007 is a small molecule commercialized by Atai Life Sciences, with a leading Phase II program in Cognitive Impairment Associated With Schizophrenia (CIAS).